Increased incidence of angiodysplasia of the gastrointestinal tract and bleeding in patients with continuous flow left ventricular assist devices (LVADs)

International Journal of Artificial Organs

Volumn 36, Issue 7, 2013, Pages 449-454

  Muthiah, Kavitha ^a   Robson, Desiree ^a   Macdonald, Peter S ^a   Keogh, Anne M ^a   Kotlyar, Eugene ^a   Granger, Emily ^a   Dhital, Kumud ^a   Spratt, Phillip ^a   Jansz, Paul ^a   Hayward, Christopher S ^a  

^a ST VINCENT S HOSPITAL   (Australia)

Author keywords

Angiodysplasia; Gastrointestinal bleeding; Incidence; Ventricular assist devices

Indexed keywords

CENTRIFUGATION; LEFT VENTRICULAR ASSIST DEVICES;

ANGIODYSPLASIAS; BLEEDINGS; CLINICAL PRACTICES; CONTINUOUS-FLOW; GASTROINTESTINAL; GASTROINTESTINAL BLEEDING; GASTROINTESTINAL TRACT; HEART FAILURE; INCIDENCE; VENTRICULAR ASSIST DEVICE;

ENDOSCOPY;

ADULT; AGED; ANGIODYSPLASIA; ARTICLE; DISEASE ASSOCIATION; DIVERTICULOSIS; ENDOSCOPY; GASTROINTESTINAL HEMORRHAGE; HEART FAILURE; HUMAN; INCIDENCE; LEFT VENTRICULAR ASSIST DEVICE; MAJOR CLINICAL STUDY; MALE; RETROSPECTIVE STUDY; STOMACH ANTRUM VASCULAR ECTASIA;

EID: 84880940306     PISSN: 03913988     EISSN: None     Source Type: Journal    
DOI: 10.5301/ijao.5000224     Document Type: Article

References (28)

1. Frazier OH, Rose EA, Oz MC, et al; HeartMate LVAS Investigators. Left Ventricular Assist System. Multicenter clinical evaluation of the HeartMate vented electric left ventricular assist system in patients awaiting heart transplantation. J Thorac Cardiovasc Surg. 2001;122(6):1186-1195.
2. Badiwala MV, Rao V. Left ventricular device as destination therapy: are we there yet? Curr Opin Cardiol. 2009;24(2): 184-189.
3. Popov AF, Hosseini MT, Zych B, et al. Clinical experience with HeartWare left ventricular assist device in patients with end-stage heart failure. Ann Thorac Surg. 2012;93(3): 810-815.
4. Aaronson KD, Slaughter MS, Miller LW, et al; HeartWare Ventricular Assist Device (HVAD) Bridge to Transplant ADVANCE Trial Investigators. Use of an intrapericardial, continuous-flow, centrifugal pump in patients awaiting heart transplantation. Circulation. 2012;125(25):3191-3200.
5. Mehta PM, Heinsimer JA, Bryg RJ, Jaszewski R, Wynne J. Reassessment of the association between gastrointestinal arteriovenous malformations and aortic stenosis. Am J Med. 1989;86(3):275-277.
6. Lanas A, García-Rodríguez LA, Polo-Tomás M, et al. The changing face of hospitalisation due to gastrointestinal bleeding and perforation. Aliment Pharmacol Ther. 2011;33(5):585-591.
7. Foutch PG, Rex DK, Lieberman DA. Prevalence and natural history of colonic angiodysplasia among healthy asymptomatic people. Am J Gastroenterol. 1995;90(4):564-567.
8. Morgan JA, Paone G, Nemeh HW, et al. Gastrointestinal bleeding with the HeartMate II left ventricular assist device. J Heart Lung Transplant. 2012;31(7):715-718.
9. Aggarwal A, Pant R, Kumar S, et al. Incidence and management of gastrointestinal bleeding with continuous flow assist devices. Ann Thorac Surg. 2012;93(5):1534-1540.
10. Demirozu ZT, Radovancevic R, Hochman LF, et al. Arteriovenous malformation and gastrointestinal bleeding in patients with the HeartMate II left ventricular assist device. J Heart Lung Transplant. 2011;30(8):849-853.
11. Boley SJ, DiBiase A, Brandt LJ, Sammartano RJ. Lower intestinal bleeding in the elderly. Am J Surg. 1979;137(1):57-64.
12. Gunnlaugsson O. Angiodysplasia of the stomach and duodenum. Gastrointest Endosc. 1985;31(4):251-254.
13. O'Malley CM, Frumento RJ, Mets B, Naka Y, Bennett-Guerrero E. Abnormal gastric tonometric variables and vasoconstrictor use after left ventricular assist device insertion. Ann Thorac Surg. 2003;75(6):1886-1891.
14. Hernández G, Tomicic V. [Effect of catecholamines on splanchnic perfusion in sepsis]. Rev Med Chil. 1999;127(6): 719-727.
15. Baumwol J, Macdonald PS, Keogh AM, et al. Right heart failure and "failure to thrive" after left ventricular assist device: clinical predictors and outcomes. J Heart Lung Transplant. 2011;30(8):888-895.
16. Kavarana MN, Pessin-Minsley MS, Urtecho J, et al. Right ventricular dysfunction and organ failure in left ventricular assist device recipients: a continuing problem. Ann Thorac Surg. 2002;73(3):745-750.
17. Dang NC, Topkara VK, Mercando M, et al. Right heart failure after left ventricular assist device implantation in patients with chronic congestive heart failure. J Heart Lung Transplant. 2006;25(1):1-6.
18. Fitzpatrick JR III, Frederick JR, Hsu VM, et al. Risk score derived from pre-operative data analysis predicts the need for biventricular mechanical circulatory support. J Heart Lung Transplant. 2008;27(12):1286-1292.
19. Matthews JC, Koelling TM, Pagani FD, Aaronson KD. The right ventricular failure risk score a pre-operative tool for assessing the risk of right ventricular failure in left ventricular assist device candidates. J Am Coll Cardiol. 2008;51(22): 2163-2172.
20. Junquera F, Saperas E, de Torres I, Vidal MT, Malagelada JR. Increased expression of angiogenic factors in human colonic angiodysplasia. Am J Gastroenterol. 1999;94(4):1070-1076.
21. Hall JL, Grindle S, Han X, et al. Genomic profiling of the human heart before and after mechanical support with a ventricular assist device reveals alterations in vascular signaling networks. Physiol Genomics. 2004;17(3):283-291.
22. Elmunzer BJ, Padhya KT, Lewis JJ, et al. Endoscopic findings and clinical outcomes in ventricular assist device recipients with gastrointestinal bleeding. Dig Dis Sci. 2011;56(11):3241-3246.
23. Lamberts M, Olesen JB, Ruwald MH, et al. Bleeding after initiation of multiple antithrombotic drugs, including triple therapy, in atrial fibrillation patients following myocardial infarction and coronary intervention: a nationwide cohort study. Circulation. 2012;126(10):1185-1193.
24. Slaughter MS. Hematologic effects of continuous flow left ventricular assist devices. J Cardiovasc Transl Res. 2010;3(6):618-624.
25. Meyer AL, Malehsa D, Bara C, et al. Acquired von Willebrand syndrome in patients with an axial flow left ventricular assist device. Circ Heart Fail. 2010;3(6):675-681.
26. Malehsa D, Meyer AL, Bara C, Strüber M. Acquired von Willebrand syndrome after exchange of the HeartMate XVE to the HeartMate II ventricular assist device. Eur J Cardiothorac Surg. 2009;35(6):1091-1093.
27. Stern DR, Kazam J, Edwards P, et al. Increased incidence of gastrointestinal bleeding following implantation of the Heart-Mate II LVAD. J Card Surg. 2010;25(3):352-356.
28. Crow S, John R, Boyle A, et al. Gastrointestinal bleeding rates in recipients of nonpulsatile and pulsatile left ventricular assist devices. J Thorac Cardiovasc Surg. 2009;137(1):208-215.